$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is Nivolumab an O drug?
2026-02-01 22:25:32
Check Details
Can Nivolumab be combined with axitinib?
2026-02-01 22:25:32
Check Details
The difference between Nivolumab and Pembrolizumab
2026-02-01 22:25:32
Check Details
Instructions for Zanubrutinib
2026-02-01 22:25:32
Check Details
What are the precautions for taking Zanubrutinib?
2026-02-01 22:25:32
Check Details
What is Zanubrutinib?
2026-02-01 22:25:32
Check Details
Is Margetuximab (Margenza) launched in China?
2026-02-01 22:25:32
Check Details
Margetuximab (Margenza) Chinese instructions
2026-02-01 22:25:32
Check Details
How effective is margetuximab (Margenza) in treating breast cancer?
2026-02-01 22:25:32
Check Details
Margetuximab (Margenza) Adverse Reactions
2026-02-01 22:25:32
Check Details
Efficacy of Zanubrutinib
2026-02-01 22:25:32
Check Details
Margetuximab (Margenza) dosage and administration
2026-02-01 22:25:32
Check Details
1
2
...
210
211
212
213
214
215
216
...
10209
10210
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Dotinurad: An Innovative Treatment Option for Gout and Hyperuricemia
2
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
3
Anagrelide (Agrylin): Managing ET-Related Thrombocytosis
4
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
5
Azacitidine Treatment Guide: Indications, Cross-Border Purchase & Safety Tips
6
Odevixibat: Targeting IBAT to Transform Cholestatic Liver Disease Treatment
7
A Precision FGFR Inhibitor for Cholangiocarcinoma
8
A Revolutionary Targeted Therapy for Hematological Malignancies
9
A New Option for Advanced Renal Cell Carcinoma Treatment
10
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
11
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
12
Olaparib Plus Pembrolizumab Maintenance Therapy for Metastatic Pancreatic Cancer: Findings from the POLAR Phase II Basket Trial